Principal Financial Group Inc. Decreases Stock Position in Lam Research Corporation $LRCX

Principal Financial Group Inc. cut its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 7.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,970,770 shares of the semiconductor company's stock after selling 168,179 shares during the quarter. Principal Financial Group Inc. owned 0.16% of Lam Research worth $337,356,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC acquired a new position in shares of Lam Research in the 4th quarter valued at approximately $25,000. Stance Capital LLC bought a new stake in Lam Research in the third quarter valued at about $26,000. Triumph Capital Management bought a new position in Lam Research during the 3rd quarter worth approximately $27,000. Harbor Investment Advisory LLC raised its position in shares of Lam Research by 73.9% during the 4th quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company's stock valued at $41,000 after acquiring an additional 102 shares in the last quarter. Finally, WealthCollab LLC increased its stake in Lam Research by 29.3% during the fourth quarter. WealthCollab LLC now owns 243 shares of the semiconductor company's stock valued at $42,000 after purchasing an additional 55 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Earnings beat + bullish near‑term guide — Lam reported a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, which the market interpreted as accelerating wafer‑fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
• Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler‑capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising -- BUY
• Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
• Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
• Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre‑arranged Rule 10b5‑1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
• Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
• Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre‑planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Barclays set a $275.00 price objective on shares of Lam Research and gave the stock an "equal weight" rating in a research note on Thursday, April 23rd. Weiss Ratings raised shares of Lam Research from a "buy (b-)" rating to a "buy (b)" rating in a report on Friday, April 24th. Zacks Research lowered shares of Lam Research from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 6th. UBS Group set a $300.00 price target on Lam Research in a report on Thursday, January 29th. Finally, Evercore boosted their price objective on Lam Research from $275.00 to $300.00 and gave the stock an "outperform" rating in a research report on Thursday, April 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat, Lam Research presently has a consensus rating of "Moderate Buy" and an average price target of $285.94.

Lam Research Price Performance

NASDAQ:LRCX opened at $275.80 on Wednesday. The business's 50-day moving average price is $236.99 and its 200 day moving average price is $202.86. The firm has a market cap of $344.91 billion, a P/E ratio of 52.04, a PEG ratio of 2.14 and a beta of 1.81. Lam Research Corporation has a 52-week low of $72.59 and a 52-week high of $280.00. The company has a quick ratio of 1.77, a current ratio of 2.54 and a debt-to-equity ratio of 0.35.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, beating analysts' consensus estimates of $1.36 by $0.11. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The company had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. During the same period in the prior year, the company earned $1.04 EPS. Lam Research's revenue was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 5.68 earnings per share for the current fiscal year.

Insider Buying and Selling at Lam Research

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Neil J. Fernandes sold 18,170 shares of the firm's stock in a transaction on Friday, May 1st. The stock was sold at an average price of $255.14, for a total value of $4,635,893.80. Following the sale, the senior vice president directly owned 66,129 shares of the company's stock, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 155,066 shares of company stock valued at $35,849,242 in the last ninety days. Company insiders own 0.31% of the company's stock.

Lam Research Company Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.